Issued Patents 2024
Showing 1–11 of 11 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12180520 | Engineered CRISPR-Cas9 nucleases with altered PAM specificity | Benjamin Kleinstiver | 2024-12-31 |
| 12173339 | Variants of Cpf1 (Cas12a) with altered PAM specificity | Benjamin Kleinstiver, Alexander Sousa | 2024-12-24 |
| 12152254 | TAL-Tet1 fusion proteins and methods of use thereof | Morgan Maeder, James Angstman | 2024-11-26 |
| 12133884 | Methods of substituting pathogenic amino acids using programmable base editor systems | David Bryson, John W. Evans, Michael S. Packer, Yanfang Fu, Nicole Gaudelli +1 more | 2024-11-05 |
| 12104207 | Genomewide unbiased identification of DSBs evaluated by sequencing (GUIDE-Seq) | Shengdar Tsai | 2024-10-01 |
| 12065668 | RNA-guided targeting of genetic and epigenomic regulatory proteins to specific genomic loci | Morgan Maeder | 2024-08-20 |
| 11976324 | Highly sensitive in vitro assays to define substrate preferences and sites of nucleic-acid binding, modifying, and cleaving agents | Vikram Pattanayak, Karl Petri, Kanae Esther Sasaki | 2024-05-07 |
| 11946040 | Adenine DNA base editor variants with reduced off-target RNA editing | Julian Grunewald, Ronghao Zhou | 2024-04-02 |
| 11920152 | Increasing specificity for RNA-guided genome editing | James Angstman, Shengdar Tsai | 2024-03-05 |
| 11898203 | Highly sensitive in vitro assays to define substrate preferences and sites of nucleic-acid binding, modifying, and cleaving agents | Vikram Pattanayak, Karl Petri | 2024-02-13 |
| 11859220 | Engineered CRISPR-Cas9 nucleases with altered PAM specificity | Benjamin Kleinstiver | 2024-01-02 |